Díaz RCA, Capera LLF

Language: Spanish
References: 15
Page: 516-520
PDF size: 217.45 Kb.

ABSTRACT

Background: Endometrial polyps are overgrowths of the endometrial mucosa, one of the most common causes of abnormal uterine bleeding and may be associated with premalignant and malignant endometrial lesions. There are hysteroscopic features that help differentiate a benign or malignant lesion. Metaplastic polyp is a hysteroscopic finding characterized by lamellar surfaces and hyperkeratosis, with white and hyperreflective areas.
Clinical cases: Three clinical cases of patients under 40 years of age, with abnormal uterine bleeding where the common hysteroscopic finding was metaplastic polyp, a premalignant finding that was confirmed by pathological analysis and positivity of the immunohistochemistry marker p63. Case 1. 28-year-old female, nulliparous, obese, with a history of polycystic ovary syndrome, with endometrial thickening and hysteroscopy, with polyp with hyperkeratotic surface, in the form of irregular sheets, with excrescences and exophytic lesions. Case 2. 25-year-old patient, with irregular thickened endometrium and hysteroscopy with finding of transparent polyps, with mild vascular changes and surface with whitish hyperrefringent areas. Case 3. 38-year-old patient with a history of polycystic ovary syndrome and obesity. At hysteroscopy the endometrium was found to be irregularly hyperplastic, with vascular changes and polyps with hyper-refringent, solid, white superficial areas.
Conclusions: In young patients, with hysteroscopic finding of metaplastic polyp should be considered and premalignant and malignant endometrial disease should be ruled out. The study should be completed with immunohistochemical markers (p63), specific for squamous metaplasia.

REFERENCES

1. Shveiky D, Rojansky N, Revel A, Benshushan A, et al. Complicationsof hysteroscopic surgery: "Beyond the learningcurve". J Minim Invasive Gynecol 2007; 14 (2): 218-22.https://doi.org/10.1016/j.jmig.2006.07.019

2. Hamani Y, Eldar I, Sela HY, Voss E, et al. The clinicalsignificance of small endometrial polyps. Eur J ObstetGynecol Reprod Biol 2013; 170 (2): 497-500. https://doi.org/10.1016/j.ejogrb.2013.07.011

3. Bradley L, Falcone T. Hysteroscopy: office evaluation andmanagement of the uterine cavity. 1st ed. Mosby Elseiver2009; 237-38.

4. Cohen I, Azaria R, Bernheim J, Shapira J, et al. Risk factorsof endometrial polyps resected from postmenopausal patientswith breast carcinoma treated with tamoxifen. Cancer2001; 92 (5): 1151-55. https://doi.org/10.1002/1097-0142(20010901)92:5<1151::aid-cncr1433>3.0.co;2-y

5. Wang JH, Zhao J, Lin J. Opportunities and risk factors forpremalignant and malignant transformation of endometrialpolyps: management strategies. J Minim InvasiveGynecol. 2010; 17 (1): 53-58. https://doi.org/10.1016/j.jmig.2009.10.012

6. Ghoubara A, Sundar S, Ewies AAA. Predictors of malignancyin endometrial polyps: study of 421 women with postmenopausalbleeding. Climacteric 2018; 21 (1): 82-87. https://doi.org/10.1080/13697137.2017.1410783

7. Ngo YG, Fu HC, Chu LC. Specific hysteroscopic findings canefficiently distinguish the differences between malignant andbenign endometrial polyps. Taiwan J Obstet Gynecol 2020;59 (1): 85-90. https://doi.org/10.1016/j.tjog.2019.11.013

8. Bhardwaj N, Diwaker P, Gogoi P, Wadhwa N, et al. Ichthyosisuteri associated with endometrial adenocarcinoma: a casereport. J Clin Diagn Res 2017; 11 (6): ED24-ED25. https://doi.org/10.7860/JCDR/2017/27951.10116

9. Hendrickson MR, Kempson RL. Endometrial epithelialmetaplasias: proliferations frequently misdiagnosed asadenocarcinoma. Report of 89 cases and proposed classification.Am J Surg Pathol 1980; 4 (6): 525-42. https://doi.org/10.1097/00000478-198012000-00004

10. Nicolae A, Preda O, Nogales FF. Endometrial metaplasiasand reactive changes: a spectrum of altered differentiation.J Clin Pathol 2011; 64 (2): 97-106. https://doi.org/10.1136/jcp.2010.085555

11. Espíndola D, Kennedy KA, Fischer EG. Management ofabnormal uterine bleeding and the pathology of endometrialhyperplasia. 2007; 34(4), –737. doi:10.1016/j.ogc.2007.09.001

12. Litta P, Codroma A, D'Agostino G, Breda E. Morular endometrialmetaplasia: review of the literature and proposalof the management. Eur J Gynaecol Oncol 2013; 34 (3):243-47. https://article.imrpress.com/journal/EJGO/34/3/pii/1630906232499-197628245/243-247.pdf

13. Lax SF. Vorläuferläsionen der Endometriumkarzinome [Precursorlesions of endometrial carcinoma]. Pathologe 2019;40 (1): 13-20. https://doi.org/10.1007/s00292-019-0568-5

14. Nogueira AA, Sant'Ana de Almeida EC, Poli Neto OB,Zambelli Ramalho LN, et al. Immunohistochemical expressionof p63 in endometrial polyps: evidence that abasal cell immunophenotype is maintained. Menopause2006; 13 (5): 826-30. https://doi.org/10.1097/01.gme.0000242274.32278.a2

15. Houghton O, McCluggage WG. The expression and diagnosticutility of p63 in the female genital tract. Adv AnatPathol 2009; 16 (5): 316-21. https://doi.org/10.1097/PAP.0b013e3181b507c6